Otterstad J E, Lubsen K, Parker A, Kirwan B, Plappert T, St John Sutton M G
Division of Cardiology, Vestfold Central Hospital, Tønsberg, Norway.
Scand Cardiovasc J. 1999;33(4):234-41. doi: 10.1080/14017439950141678.
Left ventricular (LV) remodelling following acute myocardial infarction has generally been studied in patients with LV ejection fraction (EF) < 40%, and it has been shown that this process can be attenuated by ACE inhibitors. Little is known regarding LV remodelling in patients with LVEF > or = 40% or the effects of treatment in this patient cohort. The DEFIANT II study (Doppler Flow and Echocardiography in Functional cardiac insufficiency) included 542 post-infarction patients with LVEF 25-50% without overt heart failure within 13 days following acute myocardial infarction (AMI). They were then randomized to nisoldipine coat-core (CC) or placebo and followed up for 6 months.
Two-dimensional echoes were obtained after 8 (5-13) days and 6 months following AMI.
LV end diastolic (ED) and end systolic (ES) volumes (V) were calculated in 503 patients with technically satisfactory paired echoes using the biplabe method of discs in a core laboratory.
Group A. 217 patients with baseline EF 40-50%, of whom 112 were randomized to nisoldipine and 104 to placebo (one patient was taken off study medication). Group B. 286 patients with EF 25-39%, of whom 145 were randomized to nisoldipine and 141 to placebo.
LVEDV was 175 (+/-45) ml in Group A vs 203 (+/-49) ml in Group B (p = 0.001) at baseline and 184 (+/-48) ml vs 213 (+/-56) ml (p = 0.001), respectively, at 6 months. LVESV at baseline was 97 (+/-42) ml in Group A vs 133 (+/-37) ml in Group B (p = 0.001), and 106 (+/-34) ml vs 134 (+/-45) ml (p = 0.001) at 6 months, respectively. The increase of LVESV was 9 (+/-29) ml in Group A vs 2 (+/-35) ml in Group B (p = 0.007). LVEF decreased by 2 (+/-6)% in Group A vs an increase of 3 (+/-6)% in Group B (p = 0.001). Treatment with nisoldipine had no influence on LV volumes in either of the two groups or in the total study group.
LV dilatation 6 months following AMI in patients with EF 40-50% was similar in end diastole, but more pronounced in end systole vs patients with EF 25-39%. LV remodelling did not change significantly after nisoldipine treatment.
急性心肌梗死后左心室(LV)重构通常是在左心室射血分数(EF)<40%的患者中进行研究,并且已经表明这一过程可被血管紧张素转换酶抑制剂减弱。对于LVEF>或=40%的患者的LV重构情况或该患者群体的治疗效果知之甚少。DEFIANT II研究(功能性心脏功能不全中的多普勒血流与超声心动图)纳入了542例急性心肌梗死(AMI)后13天内LVEF为25 - 50%且无明显心力衰竭的梗死患者。然后将他们随机分为尼索地平包衣片(CC)组或安慰剂组,并随访6个月。
在AMI后8(5 - 13)天和6个月时获取二维超声心动图。
在核心实验室中,使用双平面圆盘法在503例技术上获得满意配对回声的患者中计算左心室舒张末期(ED)和收缩末期(ES)容积(V)。
A组。217例基线EF为40 - 50%的患者,其中112例随机分配至尼索地平组,104例分配至安慰剂组(1例患者退出研究用药)。B组。286例EF为25 - 39%的患者,其中145例随机分配至尼索地平组,141例分配至安慰剂组。
基线时,A组的LVEDV为175(±45)ml,B组为203(±49)ml(p = 0.001);6个月时,分别为184(±48)ml和213(±56)ml(p = 0.001)。基线时,A组的LVESV为97(±42)ml,B组为133(±37)ml(p = 0.001);6个月时,分别为106(±34)ml和134(±45)ml(p = 0.001)。A组LVESV的增加为9(±29)ml,B组为2(±35)ml(p = 0.007)。A组的LVEF下降了2(±6)%,而B组增加了3(±6)%(p = 0.001)。尼索地平治疗对两组中的任何一组或整个研究组的LV容积均无影响。
EF为40 - 50%的患者在AMI后6个月时,舒张末期的LV扩张情况相似,但收缩末期比EF为25 - 39%的患者更明显。尼索地平治疗后LV重构无明显变化。